Department of Molecular and Translational Sciences, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States.
Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, MD, United States.
Microb Pathog. 2019 Dec;137:103742. doi: 10.1016/j.micpath.2019.103742. Epub 2019 Sep 9.
Low molecular mass penicillin binding proteins (LMM PBP) are bacterial enzymes involved in the final steps of peptidoglycan biosynthesis. In Escherichia coli, most LMM PBP exhibit dd-carboxypeptidase activity, are not essential for growth in routine laboratory media, and contributions to virulent phenotypes remain largely unknown. The Francisella tularensis Schu S4 genome harbors the dacD gene (FTT_1029), which encodes a LMM PBP with homology to PBP6b of E. coli. Disruption of this locus in the fully virulent Schu S4 strain resulted in a mutant that could not grow in Chamberlain's Defined Medium and exhibited severe morphological defects. Further characterization studies demonstrated that the growth defects of the dacD mutant were pH-dependent, and could be partially restored by growth at neutral pH or fully restored by genetic complementation. Infection of murine macrophage-like cells showed that the Schu S4 dacD mutant is capable of intracellular replication. However, this mutant was attenuated in BALB/c mice following intranasal challenge (LD = 603 CFU) as compared to mice challenged with the parent (LD = 1 CFU) or complemented strain (LD = 1 CFU). Additionally, mice that survived infection with the dacD mutant showed significant protection against subsequent challenge with the parent strain. Collectively, these results indicate that the DacD protein of F. tularensis is essential for growth in low pH environments and virulence in vivo. These results also suggest that a PBP mutant could serve as the basis of a novel, live attenuated vaccine strain.
低分子量青霉素结合蛋白(LMM PBP)是参与肽聚糖生物合成最后步骤的细菌酶。在大肠杆菌中,大多数 LMM PBP 表现出 dd-羧肽酶活性,对于常规实验室培养基中的生长不是必需的,并且对毒力表型的贡献在很大程度上仍然未知。土拉弗朗西斯菌 Schu S4 基因组含有 dacD 基因(FTT_1029),该基因编码一种与大肠杆菌 PBP6b 同源的 LMM PBP。在完全毒力的 Schu S4 菌株中破坏该基因座导致不能在 Chamberlain 定义培养基中生长的突变体,并表现出严重的形态缺陷。进一步的表征研究表明,dacD 突变体的生长缺陷依赖于 pH 值,并且可以通过在中性 pH 值下生长部分恢复,或者通过遗传互补完全恢复。感染鼠巨噬样细胞表明,Schu S4 dacD 突变体能在细胞内复制。然而,与用亲本(LD = 1 CFU)或互补菌株(LD = 1 CFU)挑战的小鼠相比,用滴鼻途径挑战的 BALB/c 小鼠中,Schu S4 dacD 突变体的毒力减弱(LD = 603 CFU)。此外,感染 dacD 突变体的小鼠在随后用亲本菌株再次感染时表现出显著的保护作用。总的来说,这些结果表明土拉弗朗西斯菌的 DacD 蛋白对于在低 pH 环境中的生长和体内毒力是必需的。这些结果还表明,PBP 突变体可以作为新型活减毒疫苗菌株的基础。